BIOCHEMICAL METHODS FOR DETECTING CERVICAL DYSPLASIA AND CANCER

摘要

Primary screening for cervical dysplasia is effected by measuringa biochemical marker of apoptosis and/or angiogenesis in each of a population of cells derived from convenient, superficial swabbing, sponging, scraping or lavage of superficial eptithelial cells from the cervix, wherein the marker indicates the presence of cervical dysplasia in the sample, and scoring the results of the measuring step for cervical displasia (i.e. ascertaining whether or not the marker is present) in the patient in the absence of any cythological examination.